Prenatal treatment of congenital adrenal hyperplasia-not standard of care (Q38013728)

27 August 2017

Prenatal treatment of congenital adrenal hyperplasia-not standard of care (English)

1 reference

27 August 2017

0 references

Selma Feldman Witchel

series ordinal

1

1 reference

PubMed ID

22639328

27 August 2017

Walter L Miller

series ordinal

2

1 reference

27 August 2017

26 May 2012

1 reference

Journal of Genetic Counseling

27 August 2017

1 reference

27 August 2017

21

1 reference

27 August 2017

615-624

1 reference

27 August 2017

5

1 reference

Multiple courses of antenatal corticosteroids for preterm birth study: 2-year outcomes.

27 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Weight in infancy and death from ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Fetal and placental size and risk of hypertension in adult life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Review and meta-analysis: Benefits and risks of multiple courses of antenatal corticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Congenital adrenal hyperplasia: a critical appraisal of the evolution of feminizing genitoplasty and the controversies surrounding gender reassignment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an update of new CYP21A2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Sexual function and genital sensitivity following feminizing genitoplasty for congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Maternal dexamethasone treatment at midgestation reduces nephron number and alters renal gene expression in the fetal spiny mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Prenatal diagnosis and treatment of 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Teratogenic potential of corticosteroids in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Glucocorticoids, prenatal stress and the programming of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Gender role behaviour in prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia--a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

The mother or the fetus? 11beta-hydroxysteroid dehydrogenase type 2 null mice provide evidence for direct fetal programming of behavior by endogenous glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Effect of corticosteroids on brain growth in fetal sheep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Serum cortisol, dehydroepiandrosterone sulfate, and steroid-binding globulins in preterm neonates: effect of gestational age and dexamethasone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Duplications of the functional CYP21A2 gene are primarily restricted to Q318X alleles: evidence for a founder effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Cortisol production rate in childhood and adolescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Antenatal glucocorticoids and the developing brain: mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

The molecular genetics of 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Effects into adulthood of single or repeated antenatal corticosteroids in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Sexual function and surgical outcome in women with congenital adrenal hyperplasia due to CYP21A2 deficiency: clinical perspective and the patients' perception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

High frequency of copy number variations and sequence variants at CYP21A2 locus: implication for the genetic diagnosis of 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Health problems in congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Corticosteroids during pregnancy and oral clefts: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

The efficacy of methylprednisolone in the treatment of hyperemesis gravidarum: a randomized, double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Prenatal glucocorticoids and long-term programming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

How safe is long-term prenatal glucocorticoid treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Synthetic glucocorticoids: antenatal administration and long-term implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Genotype of Yupik Eskimos with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Prenatal diagnosis and treatment of steroid 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Congenital adrenal hyperplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Presence of fetal DNA in maternal plasma and serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

EXTENSIVE PERSONAL EXPERIENCE: Prenatal Diagnosis for Congenital Adrenal Hyperplasia in 532 Pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Type of Mutation and Surgical Procedure Affect Long-Term Quality of Life for Women with Congenital Adrenal Hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Human foetal palatal corticoid receptors and teratogens for cleft palate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9508-8

Pharmacologic suppression of the fetal adrenal gland in utero. Attempted prevention of abnormal external genital masculinization in suspected congenital adrenal hyperplasia

21 January 2018

1 reference

12 December 2020

Prenatal treatment of congenital adrenal hyperplasia

1 reference

12 December 2020

Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate

1 reference

12 December 2020

Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency

1 reference

12 December 2020

Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology

1 reference

12 December 2020

Dexamethasone treatment of congenital adrenal hyperplasia in utero: an experimental therapy of unproven safety

1 reference

12 December 2020

High frequency of nonclassical steroid 21-hydroxylase deficiency

1 reference

12 December 2020

Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia

1 reference

12 December 2020

Prenatal dexamethasone causes oligonephronia, sodium retention, and higher blood pressure in the offspring

1 reference

12 December 2020

Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: characteristics of three unusual haplotypes

1 reference

12 December 2020

Technical report: congenital adrenal hyperplasia. Section on Endocrinology and Committee on Genetics

1 reference

12 December 2020

Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society

1 reference

12 December 2020

An update on the frequency of nonclassic deficiency of adrenal 21-hydroxylase in the Yugoslav population

1 reference

12 December 2020

Fetal sex determination from maternal blood at 6 weeks of gestation when at risk for 21-hydroxylase deficiency

1 reference

12 December 2020

Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint

1 reference

12 December 2020

Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies

1 reference

12 December 2020

The steroid hormonal milieu of the undisturbed human fetus and mother at 16-20 weeks gestation

1 reference

12 December 2020

Corticosteroid teratogenicity

1 reference

12 December 2020

Prenatal treatment of congenital adrenal hyperplasia: a commentary

1 reference

12 December 2020

Malformation surveillance and maternal drug exposure: the MADRE project

1 reference

12 December 2020

Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency

1 reference

12 December 2020

Population-based case-control study of teratogenic potential of corticosteroids

1 reference

12 December 2020

Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension?

1 reference

12 December 2020

Clinical review 54: Genetics, diagnosis, and management of 21-hydroxylase deficiency

1 reference

12 December 2020

Reduced maternal dexamethasone dosage for the prenatal treatment of congenital adrenal hyperplasia

1 reference

12 December 2020

Production of congenital defects in the off-spring of pregnant mice treated with cortisone; progress report

1 reference

12 December 2020

Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia

1 reference

12 December 2020

Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth

1 reference

12 December 2020

Inhibition of 11β-Hydroxysteroid Dehydrogenase in Pregnant Rats and the Programming of Blood Pressure in the Offspring

1 reference

12 December 2020

10.1007/S10897-012-9508-8

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

22639328